Skip to main content
. Author manuscript; available in PMC: 2013 Jul 29.
Published in final edited form as: Neuropharmacology. 2009 Mar;56(4):752–760. doi: 10.1016/j.neuropharm.2008.12.007

Fig. 3.

Fig. 3

The effects of S33138 on oral sucrose self-administration under an FR2 reinforcement schedule. Panel A shows sucrose self-administration (infusion) rates after different doses of S33138 administration. Panel B shows inactive lever presses after different doses of S33138 administration. ***p < 0.001, when compared with the vehicle control group.

HHS Vulnerability Disclosure